Sorbinil (INN) is an aldose reductase inhibitor being investigated for treatment of diabetic complications including neuropathy and retinopathy. Aldose...
4 KB (273 words) - 20:02, 20 December 2023
sopromidine (INN) soquinolol (INN) sorafenib (USAN) sorbinicate (INN) sorbinil (INN) sorbitan laurate (INN) sorbitan oleate (INN) sorbitan palmitate (INN)...
8 KB (498 words) - 23:28, 20 June 2024
Imirestat Lidorestat Minalrestat Ponalrestat Ranirestat Salfredin B11 Sorbinil Tolrestat Zenarestat Zopolrestat Natural sources reported to inhibit aldose...
6 KB (578 words) - 09:59, 12 June 2024
visibility should return to normal. Aldose reductase inhibitors, such as sorbinil, have also proven promising in preventing and reversing galactosemic cataracts...
22 KB (2,729 words) - 13:38, 31 October 2024
Caficrestat, Fidarestat, Govorestat, Ranirestat, Ponalrestat, Risarestat, Sorbinil, and Berberine, Poliumoside, Ganoderic acid are currently in clinical trials...
17 KB (1,895 words) - 04:29, 23 September 2024